Abnormal screening glucose challenge test in pregnancy and future risk of diabetes

Evidence Summaries

Level of Evidence = B
An abnormal screening glucose tolerance test in pregnancy appears to increase the future risk of diabetes.

Comment: The quality of evidence is upgraded by large magnitude of effect.

In a population-based, retrospective cohort study 1 15,381 women referred for an antepartum oral glucose tolerance test (OGTT) indicative of an abnormal 50-g glucose challenge test (GCT), but without GDM, were matched (for age, region, socioeconomic status, and year of delivery) with up to 4 other women without such referral (n = 61,237). The two cohorts were followed over a median 6.4 years for the development of diabetes. The rate of incident DM was 5.04 cases per 1000 person-years in the cohort of women who underwent an antepartum OGTT, compared with 1.74 cases per 1000 person-years in women without an OGTT. The hazard ratio for subsequent DM in women with abnormal GCT was 2.56 (95% CI 2.28 to 2.87, P < 0.0001).

References

1. Retnakaran R, Shah BR. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med 2009;26(5):474-7.  [PMID:19646185]


Copyright © 2019 Duodecim Medical Publications Limited.
Abnormal screening glucose challenge test in pregnancy and future risk of diabetes is a sample topic from the Evidence-Based Medicine Guidelines.

To view other topics, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Complete Product Information.